Cimetidine in anastomotic ulceration after partial gastrectomy

Area of Science:

• Gastroenterology
• Pharmacology
• Surgical Outcomes

Background:

• Anastomotic ulcers are a complication following partial gastrectomy.
• Effective treatment options for these ulcers are crucial for patient recovery.

Purpose of the Study:

• To evaluate the efficacy of cimetidine in treating anastomotic ulcers after partial gastrectomy.
• To assess symptom relief and long-term outcomes associated with cimetidine therapy.

Main Methods:

• A double-blind, prospective clinical trial was conducted.
• 21 patients with anastomotic ulcers were enrolled.
• Patients received either cimetidine (1g daily) or a placebo for 4 weeks, followed by maintenance therapy.

Main Results:

• A significantly higher healing rate was observed in the cimetidine group (8/12) compared to placebo (1/9) after 4 weeks (P < 0.05).
• Symptom relief was also superior in patients treated with cimetidine.
• The healing rate reached 86% after 2 months of cimetidine treatment.
• During 1 year of maintenance therapy (800mg daily), only 3 out of 19 patients relapsed.
• No serious adverse events were reported.

Conclusions:

• Cimetidine demonstrates a beneficial effect on the healing of anastomotic ulcers.
• Cimetidine provides significant symptom relief in patients with post-gastrectomy anastomotic ulcers.
• The drug is well-tolerated and effective for both initial treatment and maintenance therapy.